Clinical trial
Minimum Alveolar Concentration of Sevoflurane for Maintaining BIS Below 50 in Patients Undergoing Coronary Artery Bypass Grafting During Normothermic Cardiopulmonary Bypass Phase.
NCT02711384 is registered in ClinicalTrials.gov with Instituto Dante Pazzanese de Cardiologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimum Alveolar Concentration of Sevoflurane for Maintaining BIS Below 50 in Patients Undergoing Coronary Artery Bypass Grafting During Normothermic Cardiopulmonary Bypass Phase.
- Lead sponsor
- Instituto Dante Pazzanese de Cardiologia
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 25, 2018
- Completion date
- February 28, 2020
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.